Studies chronic myeloid leukemia in children and adolescents
Describes chronic myeloid leukemia and its treatment in young patients under 18.
Plain-language title generated from the registry record
Registry title: International Chronic Myeloid Leukemia Pediatric Study
Key facts
- Where
- Athens, GreeceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- How old is the patient who may join a trial?
- What type of cancer has the patient been diagnosed with?
Source: NCT01281735, who can take part
Where in Greece
- Agia Sophia Children's HospitalAthens, GreeceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Poitiers University Hospital
- Trial code
- NCT01281735
- Record updated
- 17 January 2024
- Original description
The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.Read full original descriptionShow less
INTERNATIONAL STUDY of Chronic Myeloid Leukaemia (CML) Treatment and Outcomes in Children and Adolescents
The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.
Inclusion: patients less than 18 years of age; diagnosed Philadelphia positive and/or BCR-ABL positive Chronic Myeloid Leukemia (CML) all phases.
Exclusion: patients more than 18 years of age at diagnosis of CML.